Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30

$1.66−0.03 (-1.78%)

Close on Nov 12, 2026Market cap $590.23MP/E –Yield –

Evotec EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Evotec's EV/EBITDA was 4.7× on Nov 11, 2026, against 26.3× a year earlier. Over the last 5 years it ranged from 3.5× to 141.5×, with a median of 30.4×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	4.7×	−20.9
2025	Feb 28, 2025	25.5×	+2.6
2024	Dec 31, 2024	22.9×	−12.3
2023	Dec 29, 2023	35.2×	+14.3
2022	Dec 30, 2022	21.0×	−119.2
2021	Dec 31, 2021	140.1×	+72.9
2020	Dec 31, 2020	67.2×	–